Structure Therapeutics (GPCR) Accumulated Depreciation (2022 - 2025)

Structure Therapeutics' Accumulated Depreciation history runs 4 years deep, the most recent figure standing at $3.0 million for Q4 2025.

• On a quarterly basis, Accumulated Depreciation rose 81.48% year-over-year to $3.0 million in Q4 2025; TTM through Dec 2025 was $3.0 million, a 81.48% increase from a year earlier, with the FY2025 full-year figure at $3.0 million, up 81.48% from the prior year.
• Accumulated Depreciation climbed to $3.0 million in Q4 2025 per GPCR's latest filing, from $1.6 million in the prior quarter.
• Across five years, Accumulated Depreciation topped out at $3.0 million in Q4 2025 and bottomed at $349000.0 in Q4 2022.
• The 4-year median for Accumulated Depreciation is $755000.0 (2023), against an average of $1.0 million.
• Across the five-year window, Accumulated Depreciation soared 154.04% in 2024 and jumped 81.48% in 2025, its largest moves.
• Year by year, Accumulated Depreciation stood at $349000.0 in 2022, then surged by 84.53% to $644000.0 in 2023, then jumped by 154.04% to $1.6 million in 2024, then soared by 81.48% to $3.0 million in 2025.
• Per Business Quant, the three latest GPCR Accumulated Depreciation figures stand at $3.0 million (Q4 2025), $1.6 million (Q4 2024), and $1.4 million (Q3 2024).